Engineers, Particularly Software Engineers, Have Long Supported SENS Rejuvenation Research
The SENS approach to the treatment of aging is explicitly engineering, in the sense that engineering is the application of science to produce useful technology in absence of full knowledge of the systems influenced. It is right there in the name: Strategies for Engineered Negligible Senescence. In fact all medicine is engineering, as no-one yet has access to the full map of cellular biology that would allow for complete knowledge of how any particular therapy actually functions. SENS is merely a particularly obvious example, perhaps because of the great divide that exists in the aging research community. Firstly, th...
Source: Fight Aging! - December 20, 2018 Category: Research Authors: Reason Tags: Activism, Advocacy and Education Source Type: blogs

Empirical Evidence for Stock-Market Short-Termism?
This blog post is part of a larger series on stock-market “short-termism”. See also my entries onshare buybacks and progressivecorporate governance reforms.I. IntroductionTo recapitulate the “myopia thesis”: managers of publicly traded firms are hostage to diversified shareholders who forego careful study of the firm’s fundamentals and instead respond to the latest, easily digestible quarterly earnings report. Rather than undertaking investments that might have a substantial retu rn down the road, managers mimic the priorities of transient shareholders uninterested in a firm’s long-term strategy. Future-orien...
Source: Cato-at-liberty - December 18, 2018 Category: American Health Authors: Derek Bonett Source Type: blogs

Why Is the U.S. Economy Successful?
In a recenttalk, my Harvard colleague Martin Feldstein posits ten answers:An entrepreneurial culture. Individuals in the U.S. demonstrate a desire to start businesses and to grow them. There is little opprobrium in the U.S. for failing and starting again.A financial system that supports entrepreneurship. The United States has a more developed system of equity finance than the countries of Europe, including angel investors who are willing to finance startups and a very active venture capital market that helps finance those firms as they grow. The U.S. also has a large decentralized banking system with more than 7,000 sm...
Source: Cato-at-liberty - December 13, 2018 Category: American Health Authors: Jeffrey Miron Source Type: blogs

The Perils of CEO Worship - What Happens When the Leader Becomes Demented?
Introduction: the Cult of the CEOAlthough the US and most developed countries are nominally democratic, many of us seem to be again yearning for a man on a white horse, and in the current era, the horse ridden is corporate.On Health Care Renewal, we having been talking about this pheonomenon for a long time. We have written about it in terms ofthe messianic (or visionary, or charistmatic) CEO,CEO disease, and theimperial CEO.These concerns are diffusing into the broader media.  For example, from the introduction to a revent Vox article entitled "The Problem with CEO Worship"Society has always had heroes, be those of w...
Source: Health Care Renewal - December 2, 2018 Category: Health Management Tags: accountability anechoic effect CEO disease Donald Trump imperial CEO leadership Source Type: blogs

Share Buybacks: Mismeasured and Misunderstood
In March of this year,Forbespublished an article with the following lede:The Economist has called them “an addiction to corporate cocaine.” Reuters has called them “self-cannibalization.” The Financial Timeshas called them “an overwhelming conflict of interest.” In an article that won the HBR McKinsey Award for the best article of the year, Harvard Business Review has called them “stock price manipulation.” These influential journals make a powerful case that wholesale stock buybacks are a bad idea—bad economically, bad financially, bad socially, bad legally and bad morally.There is no shortage of ...
Source: Cato-at-liberty - November 30, 2018 Category: American Health Authors: Derek Bonett Source Type: blogs

Tech Tonics Podcast: Margaret Laws – Where Non-Profit & For-Profit Healthcare Innovation Collide
Margaret Laws has been working at the intersection of the for-profit and not-for-profit healthcare world for many years. This world has had an explosion of activity to find solutions to major public health and personal health challenges; according to Margaret, these worlds are beginning to blur and the newest foundations and non-profits are actively trying to bring the resources and discipline of private business sector to the big problems we are facing in the social sector. Her life’s work has been to straddle both of these worlds and try to bring them together. Today Margaret is CEO of HopeLab, an Omidyar Group ent...
Source: Disruptive Women in Health Care - November 30, 2018 Category: Consumer Health News Authors: dw at disruptivewomen.net Tags: Uncategorized Source Type: blogs

Fight Aging! Newsletter, November 26th 2018
This study is the culmination of a decade of research that has repeatedly demonstrated that this vaccine can effectively and safely target in animal models what we think may cause Alzheimer's disease. I believe we're getting close to testing this therapy in people." Although earlier research established that antibodies significantly reduce amyloid buildup in the brain, researchers needed to find a safe way to introduce them into the body. A vaccine developed elsewhere showed promise in the early 2000s, but when tested in humans, it caused brain swelling in some patients. The new idea was to start with DNA coding for...
Source: Fight Aging! - November 25, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

On Giving Tuesday, Help to Build a Future in which Aging is Controlled and Age-Related Diseases No Longer Exist
Giving Tuesday is just a few days away, the better sibling of earlier days of mandated commerce. Whatever your thoughts on top-down collectivism, there are worse things in the world than a successful movement to prompt people into thinking about the causes they support in principle, and encourage them to make that support material. Philanthropy is a very necessary part of our society, and particularly in the case of technological progress. Established sources of funding for medial research and development, even those we might think of as having an appetite for risk, such as venture capital funds, are in fact very conservat...
Source: Fight Aging! - November 23, 2018 Category: Research Authors: Reason Tags: Activism, Advocacy and Education Source Type: blogs

Fight Aging! Newsletter, November 19th 2018
Fight Aging! provides a weekly digest of news and commentary for thousands of subscribers interested in the latest longevity science: progress towards the medical control of aging in order to prevent age-related frailty, suffering, and disease, as well as improvements in the present understanding of what works and what doesn't work when it comes to extending healthy life. Expect to see summaries of recent advances in medical research, news from the scientific community, advocacy and fundraising initiatives to help speed work on the repair and reversal of aging, links to online resources, and much more. This content is...
Source: Fight Aging! - November 18, 2018 Category: Research Authors: Reason Tags: Newsletters Source Type: blogs

The Milken Institute's Longevity Innovators Interviews
The Milken Institute has published a set of interviews with a variety of scientists and non-scientists on topics of human longevity. A few these are of interest to those of who would like to see a fast path to rejuvenation therapies unfold in the years ahead. Some of the others illustrate a point I made last week, which is that while all that really needs to happen in this field is for the biotechnologies of rejuvenation to be developed, and as quickly and directly as possible, there are those who feel that the sociological aspects of human longevity must be talked to death in advance. Thus broader advocacy initiatives ten...
Source: Fight Aging! - November 16, 2018 Category: Research Authors: Reason Tags: Healthy Life Extension Community Source Type: blogs

Points of Contention Between Hospitals and IT Companies Developing Algorithms
In a recent blog note about"big tech" knocking on hospital doors related to commercialization of diagnostic and predictive algorithms, I ended with the following statement (see:Big Tech Is Knocking on Hospital Doors; It's All About the Data). Regarding healthcare analytics in general and diagnostic analytics in particular, the development of these fields must take place in collaboration with the IT companies that have the special expertise to analyze the data using techniques such as deep learning, big data, and neural networks.Such a collaboration between these two parties will not be easy becaus...
Source: Lab Soft News - October 15, 2018 Category: Laboratory Medicine Authors: Bruce Friedman Tags: Clinical Lab Testing Electronic Health Record (EHR) Healthcare Information Technology Lab Industry Trends Lab Information Medical Consumerism Medical Research Pathology Informatics Surgical Pathology Source Type: blogs

Discussing the Longevity Investor Network
Bill Cherman and I, cofounders of Repair Biotechnologies, were recently interviewed on the topic of the Longevity Investor Network, an initiative organized by the Life Extension Advocacy Foundation volunteers. The Network is a group of angel investors and venture capitalists of varying backgrounds, all of whom are interested in the rapidly growing longevity industry. Some want to speed the advent of therapies capable of turning back aging, some are long-time fellow travelers from our broader advocacy community, some are newly arrived, just starting to learn about the science and the potential scale of this market. It is a ...
Source: Fight Aging! - October 12, 2018 Category: Research Authors: Reason Tags: Daily News Source Type: blogs

Cure Alzheimer's Fund - Progress with the Research of Alzheimer ’s Disease
You won't want to miss this year's Cure Alzheimer's Fund Symposium. The participants will be discussing the latest and most important developments in Alzheimer's research (very exciting). They will also update the newest National Institute of Health guidelines and funding for Alzheimer's research.The Cure Alzheimer's Fund's (CAF) annual research symposium takes place on Thursday, September 27.This year's topic -Progress with the Research of Alzheimer ’s DiseaseYou can watch today via a live stream on the Internet.The start button is on the Cure Alzheimer's Fund Home page. The Symposium starts at 5:30 PM (eastern time). T...
Source: Alzheimer's Reading Room, The - September 27, 2018 Category: Neurology Tags: Alzheimer research alzheimer's webinar Alzheimers Dementia charity navigator alzheimer's cure alzheimer's cure alzheimer's fund endalz science Symposium Source Type: blogs

The Biggest Trend You ’ve Probably Never Heard Of: A Status Report on 138 Healthcare ICOs
You’ve probably heard of Bitcoin, but we doubt you’ve heard of Dentacoin, MedTokens, or Curecoin. These are healthcare specific cryptocurrencies born from Initial Coin Offerings or ICOs. Over on The Health Care Blog, my colleague Robert Miller and I have written an article analyzing financial returns of 138 healthcare ICOs. The results are enlightening, but disappointing. Here are a few headlines: 122 healthcare ICOs are not exchange-listed 16 healthcare ICOs are listed on one or more exchanges Of these 16, 5 show a positive financial return since the date [...] The post The Biggest Trend You’ve Probably Never Hea...
Source: e-CareManagement - September 24, 2018 Category: Information Technology Authors: Vince Kuraitis Tags: Miscellaneous archive blockchain decentralization finance healthcare ico initial coin offering token offering venture capital Source Type: blogs